Mutational Analysis of Driver and Non-driver Mutations of Philadelphia Chromosome-negative Myeloproliferative Neoplasms; Diagnosis and Recent Advances in Treatment
Figure 4.
Structural domains of CALR showing the Type I (deletion) or Type II (insertion) mutations.